JUNTENDO UNIVERSITY
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
292
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (289 trials with phase data)• Click on a phase to view related trials
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 524
- Registration Number
- NCT05392764
- Locations
- 🇯🇵
Anjo Kosei Hospital, Anjo, Aichi, Japan
🇯🇵Aichi Medical University Hospital, Nagakute, Aichi, Japan
🇯🇵Nagoya University Hospital, Nagoya, Aichi, Japan
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
- Conditions
- EGFR Activating MutationNon-squamous Non-small-cell Lung Cancer
- Interventions
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 30
- Registration Number
- NCT05258279
- Locations
- 🇯🇵
Juntendo Urayasu Hospital, Urayasu, Chiba, Japan
🇯🇵St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
🇯🇵Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan
Induction of Transplant Tolerance in LDLT Via iTS
- Conditions
- Living-donor Liver Transplantation
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 10
- Registration Number
- NCT04950842
- Locations
- 🇯🇵
Juntendo University Hospital, Bunkyoku, Tokyo, Japan
🇯🇵Tokyo Women's Medical University Hospital, Shinjuku, Tokyo, Japan
🇯🇵Hiroshima University Hospital, Hiroshima, Japan
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
- Conditions
- Schizophrenia Relapse
- Interventions
- Drug: reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 139
- Registration Number
- NCT03019887
Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 80
- Registration Number
- NCT02324283
- Locations
- 🇯🇵
University of Juntendo, Bunkyo-ku, Tokyko, Japan
- Prev
- 1
- 2
- Next
News
Suvorexant Shows Promise in Reducing Hyperactive Delirium in Older Adults: A Randomized Clinical Trial
A clinical trial investigated suvorexant's efficacy in reducing delirium among older adults at high risk after hospitalization, a condition associated with increased morbidity and healthcare costs.